AHA: Tirzepatide Beneficial for Heart Failure With Preserved EF, Obesity
Lower risk for composite of death from cardiovascular causes or worsening heart failure seen with tirzepatide versus placebo
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.